Inovio Pharmaceuticals (INO) Enterprise Value: 66.84M

Inovio Pharmaceuticals, Inc. (INO)

1.16 -0.05 (-4.13%) USD | NASDAQ | Oct 02, 16:00

1.18 +0.02 (+1.72%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2003. Start Trial.

Date	Value
October 02, 2026	66.84M
October 01, 2026	70.96M
September 30, 2026	71.79M
September 29, 2026	62.73M
September 28, 2026	67.67M
September 25, 2026	68.49M
September 24, 2026	70.96M
September 23, 2026	74.26M
September 22, 2026	77.55M
September 21, 2026	73.43M
September 18, 2026	73.43M
September 17, 2026	70.96M
September 16, 2026	66.02M
September 15, 2026	66.84M
September 14, 2026	68.49M
September 11, 2026	74.26M
September 10, 2026	76.73M
September 09, 2026	80.02M
September 08, 2026	88.25M
September 04, 2026	89.08M
September 03, 2026	83.31M
September 02, 2026	83.31M
September 01, 2026	80.84M
August 31, 2026	75.90M
August 28, 2026	77.55M

Date	Value
August 27, 2026	75.08M
August 26, 2026	78.37M
August 25, 2026	77.55M
August 24, 2026	74.26M
August 21, 2026	68.49M
August 20, 2026	70.96M
August 19, 2026	78.37M
August 18, 2026	70.14M
August 17, 2026	66.02M
August 14, 2026	61.08M
August 13, 2026	45.44M
August 12, 2026	34.73M
August 11, 2026	34.39M
August 10, 2026	31.96M
August 07, 2026	26.33M
August 06, 2026	26.81M
August 05, 2026	27.07M
August 04, 2026	25.93M
August 03, 2026	28.70M
July 31, 2026	27.07M
July 30, 2026	25.34M
July 29, 2026	56.96M
July 28, 2026	56.14M
July 27, 2026	50.80M
July 24, 2026	51.21M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks